HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 708 Temporary Reciprocity to Ensure Access to Treatment Act S. 168, Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2148 Prescription Drug Price Relief Act S. 909, the Prescription Drug Price Relief Act H.R. 2255, the Healthcare Workforce Resilience Act S. 1024, the Healthcare Workforce Resilience Act H.R. 2471, the "Consolidated Appropriations Act" H.R. 2503, the Social Determinants Accelerator Act S. 3039, the Social Determinants Accelerator Act H.R. 3320, the Allied Health Workforce Diversity Act S. 1679, the Allied Health Workforce Diversity Act H.R. 3321, the Credit for Caring Act S. 1670, the Credit for Caring Act H.R. 3932, the "PASTEUR Act" S. 2076, the "PASTEUR Act" H.R 4131, the Better Care Better Jobs Act S. 2210, the Better Care Better Jobs Act H.R. 5030, the DIVERSE Trials Act S.2706, the DIVERSE Trials Act H.R. 5620, the "Medical and Health Stockpile Accountability Act" H.R. 6000, Cures 2.0 Act H.R. 6072, the LINC to Address Social Needs Act H.R. 7053 the Hospital Inpatient Services Modernization Act S.3792, the Hospital Inpatient Services Modernization Act S. 176, the "Ensuring Understanding of COVID-19 to Protect Public Health Act" S. 920, the Affordable and Safe Prescription Drug Reimportation Act S. 3620, the Health Data Use and Privacy Commission Act S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P FREEMAN | — |
| TINA GRANDE | — |
| MARY R GREALY | — |
| AMANDA UHEREK | — |
| DEBORAH MILLER WITCHEY | — |
Medicare/Medicaid MMM
H.R. 708 Temporary Reciprocity to Ensure Access to Treatment Act S. 168, Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2148 Prescription Drug Price Relief Act S. 909, the Prescription Drug Price Relief Act H.R. 2255, the Healthcare Workforce Resilience Act S. 1024, the Healthcare Workforce Resilience Act H.R. 2471, the "Consolidated Appropriations Act" H.R. 2503, the Social Determinants Accelerator Act S. 3039, the Social Determinants Accelerator Act H.R. 3320, the Allied Health Workforce Diversity Act S. 1679, the Allied Health Workforce Diversity Act H.R. 3321, the Credit for Caring Act S. 1670, the Credit for Caring Act H.R. 3932, the "PASTEUR Act" S. 2076, the "PASTEUR Act" H.R 4131, the Better Care Better Jobs Act S. 2210, the Better Care Better Jobs Act H.R. 5030, the DIVERSE Trials Act S.2706, the DIVERSE Trials Act H.R. 5620, the "Medical and Health Stockpile Accountability Act" H.R. 6000, Cures 2.0 Act H.R. 6072, the LINC to Address Social Needs Act H.R. 7053 the Hospital Inpatient Services Modernization Act S.3792, the Hospital Inpatient Services Modernization Act S. 176, the "Ensuring Understanding of COVID-19 to Protect Public Health Act" S. 920, the Affordable and Safe Prescription Drug Reimportation Act S. 3620, the Health Data Use and Privacy Commission Act S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P FREEMAN | — |
| TINA GRANDE | — |
| MARY R GREALY | — |
| AMANDA UHEREK | — |
| DEBORAH MILLER WITCHEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.